HEAL MS Trial: Novel Culturally-Adapted Lifestyle Intervention for Multiple Sclerosis — Multi-Omics Approach to Metabolic and Immune Dysregulation
247 Health News Editorial
·23 May 2026
·3 min read
·clinical-trialsNew HEAL MS trial investigates culturally-adapted lifestyle medicine intervention for multiple sclerosis patients using multi-omics profiling. The 12-week program targets nutrition, exercise, sleep, and stress management through digital health platforms.
Originally reported by ClinicalTrials.gov
References
- 1.New York University Abu Dhabi. (2024). HEAL MS: A Culturally Adapted Lifestyle Medicine Intervention Targeting Metabolic and Immune Dysregulation in Multiple Sclerosis Using Multi-Omics Profiling. ClinicalTrials.gov. NCT07589062. https://clinicaltrials.gov/study/NCT07589062
- 2.MS Australia. (2024). Multiple Sclerosis in Australia. https://www.msaustralia.org.au/about-ms/what-ms
- 3.Thompson, A. J., Baranzini, S. E., Geurts, J., Hemmer, B., & Ciccarelli, O. (2018). Multiple sclerosis. The Lancet, 391(10130), 1622-1636. https://doi.org/10.1016/S0140-6736(18)30481-1
- 4.Riemann-Lorenz, K., Eilers, M., von Geldern, G., Schulz, K. H., & Heesen, C. (2016). Lifestyle factors and multiple sclerosis - a systematic review of observational studies. Journal of Neurological Sciences, 367, 115-123. https://doi.org/10.1016/j.jns.2016.05.006
- 5.Jelinek, G. A., Marck, C. H., Weiland, T. J., Pereira, N., van der Meer, D. M., & Hadgkiss, E. J. (2013). Lifestyle medicine for multiple sclerosis: a multi-disciplinary intervention. Preventive Medicine, 57(5), 530-540. https://doi.org/10.1016/j.ypmed.2013.08.021
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service